St. Louis Encephalitis and West Nile Virus Encephalitis

Area of Science:

• Medical Entomology
• Neuroscience
• Public Health

Background:

• St. Louis encephalitis virus (SLEV) is a significant cause of epidemic arboviral encephalitis in the US, posing an annual public health risk.
• Mosquito-borne viral encephalitis diagnosis has been facilitated by surveillance and vector monitoring programs.
• The emergence of West Nile virus (WNV) in the US has altered the arboviral landscape, presenting challenges in diagnosis due to clinical similarities with SLEV.

Purpose of the Study:

• To highlight the diagnostic challenges posed by West Nile virus (WNV) encephalitis.
• To emphasize the need for neurologists to consider WNV alongside St. Louis encephalitis virus (SLEV) in diagnosing epidemic arboviral encephalitis.
• To inform healthcare providers about the clinical similarities between WNV and SLEV encephalitis.

Main Methods:

• Clinical and laboratory data comparison between SLEV and WNV encephalitis cases.
• Review of public health surveillance and vector monitoring data.
• Analysis of the diagnostic process for arboviral encephalitis in the context of emerging WNV.

Main Results:

• West Nile virus (WNV) encephalitis in New York presented with clinical and laboratory features similar to St. Louis encephalitis (SLEV).
• This similarity initially caused diagnostic confusion among healthcare providers.
• WNV has emerged as a significant arboviral threat in the US, requiring updated diagnostic considerations.

Conclusions:

• Neurologists must now include West Nile virus (WNV) in their differential diagnosis for epidemic mosquito-borne viral encephalitis, alongside St. Louis encephalitis virus (SLEV).
• Early recognition and supportive care are crucial for managing patients with arboviral encephalitis.
• While specific antiviral treatments are lacking, critical care and rehabilitation improve patient outcomes.